Actively Recruiting
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
Led by Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. · Updated on 2025-08-06
90
Participants Needed
1
Research Sites
24 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main purpose of this study is to evaluate the effectiveness of technetium \[99mTc\]-H7ND injection in the diagnosis of peritoneal metastasis of gastrointestinal malignant tumor. Objective: To evaluate the safety of technetium \[99mTc\]-H7ND injection in the diagnosis of peritoneal metastasis of gastrointestinal malignant tumor. Objective: To explore the diagnostic threshold of technetium \[99mTc\]-H7ND injection for peritoneal metastasis of gastrointestinal malignant tumor.
CONDITIONS
Official Title
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults over 18 years old at consent signing
- Histology or cytology confirmed gastrointestinal malignant tumor
- Scheduled for surgical removal or exploration
- Estimated survival time of at least 12 weeks
- Agree to use effective contraception during the study if of childbearing potential
- Understand the study purpose and procedures, and provide written informed consent
You will not qualify if you...
- Received anti-digestive tract tumor treatment during screening as judged by the researcher
- Symptomatic brain metastases requiring treatment
- Serious cardiovascular or cerebrovascular diseases
- Contraindications to imaging such as claustrophobia
- History of other malignant tumors
- Pregnant or lactating women
- Any other condition deemed inappropriate for study participation by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital Affiliated to Fudan University
Shanghai, China
Actively Recruiting
Research Team
H
Hongcheng Shi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here